De Vito Andrea, Geremia Nicholas, Mameli Sabrina Maria, Fiore Vito, Serra Pier Andrea, Rocchitta Gaia, Nuvoli Susanna, Spanu Angela, Lobrano Renato, Cossu Antonio, Babudieri Sergio, Madeddu Giordano
Unit of Infectious Diseases, Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy.
Department of Medical, Surgical, and Experimental Sciences, Section of Pharmacology, University of Sassari, V. le S. Pietro 43/B, 07100, Sassari, Italy.
Mediterr J Hematol Infect Dis. 2020 Sep 1;12(1):e2020056. doi: 10.4084/MJHID.2020.056. eCollection 2020.
The purpose of the present review is to give an update regarding the classification, epidemiology, clinical manifestation, diagnoses, and treatment of the diseases present in the Mediterranean area. We performed a comprehensive search, through electronic databases (Pubmed - MEDLINE) and search engines (Google Scholar), of peer-reviewed publications (articles, reviews, and books). The availability of new diagnostic tools, including Polymerase Chain Reaction and nucleotide sequencing has significantly modified the classification of intracellular bacteria, including the order Rickettsiales with more and more new species recognized as human pathogens. Furthermore, emerging species have been found in several countries and are often associated with unique clinical pictures that may challenge the physician in the early detection of the diseases. Rickettsial infections include a wide spectrum of clinical presentations ranging from a benign to a potentially life treating disease that requires prompt recognition and proper management. Recently, due to the spread of SARS-CoV-2 infection, the differential diagnosis with COVID-19 is of crucial importance. The correct understanding of the clinical features, diagnostic tools, and proper treatment can assist clinicians in the management of Rickettsioses in the Mediterranean area.
本综述的目的是更新有关地中海地区疾病的分类、流行病学、临床表现、诊断和治疗的信息。我们通过电子数据库(PubMed - MEDLINE)和搜索引擎(谷歌学术)对同行评审的出版物(文章、综述和书籍)进行了全面搜索。新诊断工具的出现,包括聚合酶链反应和核苷酸测序,显著改变了细胞内细菌的分类,包括立克次氏体目,越来越多的新物种被确认为人类病原体。此外,在几个国家发现了新出现的物种,它们通常与独特的临床症状相关,这可能会在疾病的早期检测中给医生带来挑战。立克次氏体感染包括从良性到可能危及生命的多种临床表现,需要及时识别和妥善处理。最近,由于SARS-CoV-2感染的传播,与COVID-19的鉴别诊断至关重要。正确理解临床特征、诊断工具和适当治疗可以帮助临床医生管理地中海地区的立克次氏体病。